Iatrogenic Vascular Lesions, Surgical Treatment 

  • Author: Jaime Shalkow, MD; Chief Editor: Mary C Mancini, MD, PhD   more...
 
Updated: Apr 15, 2010
 

Background

The word iatrogenic derives from Greek iatrós, which means "medicine" or "doctor," and guennan, which means "produced by." Therefore, iatrogenic refers to the consequences of the medical action. In general, an iatrogenic injury is secondary to a high-risk procedure when a lower-risk option is available; secondary to a lack of medical knowledge, negligence, careless practice, or omission; or secondary to the lack of honesty or medical ethics.

The introduction and proliferation of invasive neonatal resuscitation techniques has led to an increased incidence of vascular complications in the pediatric population. The risk of iatrogenic vascular injuries secondary to catheterization, repeated venipuncture, or arterial blood sampling has increased. In particular, transfemoral catheterization, transfemoral arteriography, and umbilical-artery catheterization used for diagnostic and monitoring purposes have been associated with thromboembolism in the lower extremities. The management of these injuries in infants and small children is distinctly different from that in adults. The small size of their vessels, severe arterial vasospasm, and the consequences of diminished blood flow on limb growth must be considered.

Next

Epidemiology

Frequency

Trauma has replaced infectious diseases as the main cause of death in children and adolescents aged 1-14 years and has become a public health problem in many parts of the world. Traumatic vascular lesions, although rare in the pediatric age group, account for 3.3-6.3% of admissions in large trauma centers.

Two thirds of pediatric arterial injuries are iatrogenic. The incidence of iatrogenic arterial injuries is increasing, especially in children younger than 2 years. Rates of arterial injury due to transfemoral cardiac catheterization are 26-67%.

The incidence of thrombosis after the use of umbilical-artery catheters is unknown. However, several reviews indicate a major complication rate of 17-20%. In one study of 4000 infants with an umbilical-artery catheter, 41 developed a major thromboembolic complication, an incidence of less than 1%.[1] Arterial complications of umbilical-artery catheters include vasospasm, aortic thrombosis, partial or complete iliac-artery thrombosis, or embolism to peripheral and visceral tissues. The position of the umbilical-artery catheters may affect the frequency of thromboembolisms. The tips of umbilical-artery catheters may be positioned high (ie, at the level of T5-T10) or low (ie, at the level of L3-L5). The optimal position to minimize thromboembolisms remains uncertain.

Arteriovenous fistulas secondary to multiple arterial punctures in neonates are rare.

Age and size are important risk factors for arterial injuries. Infants who weigh less than 10 kg are at an increased risk of vessel obstruction after cardiac catheterization. One study demonstrated an increased incidence of thromboembolism secondary to transfemoral cardiac catheterization in children younger than 10 years compared with older children. An Italian study of 2898 neonates admitted to the neonatal intensive care unit in 1987-1994 demonstrated a higher risk of iatrogenic vascular injuries in neonates with extremely low or low birth weight (2.6%) than in older neonates (0.3%).[2]

Different types of catheters used in the pediatric age group have specific associated complications.

Central venous catheters (CVCs) can lead to serious and sometimes life-threatening complications. CVCs are associated with an overall complication rate of 42-80%, including mechanical (5-19%), infectious (5-26%), or thrombotic events (2-26%). The choice of insertion site can influence the incidence and type of complication. The coagulation cascade is activated by the mere presence of a catheter in the vein, which provokes physical and chemical changes in the vascular endothelium, with hemodynamic alterations. These devices are often used in children with hematologic malignancies and hypercoagulable states.

One study revealed fibrin deposits around the catheter in 100% of patients who died while they had a CVC in place.[3] Complications reported with these vascular devices include infection, incorrect placement, phlebitis, vascular dissection and tears, hemithorax, pneumothorax, thrombosis, migration, pericardial or pleural effusion, chylothorax, peritoneal or retroperitoneal extravasation, cardiac arrhythmias, endocarditis, and pulmonary embolism.

Mechanical complications include arterial puncture or laceration, pneumothorax, hemothorax or mediastinal hematoma, misplacement of the catheter tip, puncture site hematoma or bleeding, and air embolism. About 0.5-1 mL/kg of air is sufficient to produce an air embolism in a child.

A randomized controlled trial showed that catheterization of the femoral vein was associated with a significantly increased risk of overall complications compared with catheterization of the subclavian vein, with an increased risk of catheter-related infection and thrombosis.[4] Risk factors for catheter-related mechanical complications included the following:

  • Time needed for catheter insertion (number of needle passes): More than 3 attempts were associated with a 6-fold increase in the risk of a mechanical complication.
  • Insertion during the night (operator fatigue or inexperience): Surgeons who placed over 50 CVCs had a 50% decrease in the rate of complications.
  • Center effect

The femoral site has a 5-fold increased incidence of catheter-related infectious complications compared with the subclavian approach. This risk can be reduced with the use of subcutaneous tunneling, antibiotic impregnated catheters, and the use of systemic antibiotics through the catheter.

The femoral approach also has an increased incidence of thrombotic complications (21%) compared with the subclavian catheters (1.9%). Some studies have shown that subclavian catheterization should be preferred over femoral lines whenever possible.

Patients with severe refractory hypoxemia may be at increased risk when the subclavian route is used, whereas patients with morbid obesity may be at higher risk with femoral cannulation.

Cardiac catheterization has a complication rate of 4-8%. Complications include trapping of the angioplasty balloon, vascular tears, lesions of the left pulmonary artery, mitral valve injury, coil migration, embolization, bleeding, and vascular laceration or perforation.

Lin et al (2001) reported on 1674 pediatric cardiac catheterizations performed with a femoral approach.[5] Iatrogenic inguinal lesions that required surgical repair occurred in 2%, with an overall morbidity rate of 12% and a mortality rate of 3%.

Finally, with advances in interventional catheterization, the use of large catheters and sheaths increase the risk even further.

Previous
Next

Etiology

The most common etiology of arterial thromboembolism in children is the use of catheters, including those for transfemoral cardiac catheterization, umbilical-artery catheters, and those for central or peripheral arterial lines. The mere presence of a catheter in a blood vessel is a risk factor for complications. Pediatric iatrogenic vascular lesions are secondary to arteriography, cardiac catheterism, arterial puncture, repeated blood samples, vascular access, or foreign bodies (eg, fractured or displaced guidewires or catheters). Neonatal thrombosis has been described in association with radial, femoral, pulmonary, and temporal artery lines, as well as with catheters in the femoral and jugular veins.

Surgical procedures are also a risk factor for vascular injury. Surgery-related lesions largely result from orthopedic procedures and tumor resections performed by surgical oncologists, who frequently perform large dissections in areas with distorted anatomy where the planes of dissection are usually lost and with large blood vessels involved in the tumor.

The use of partial nephrectomy or nephron-sparing surgery (NSS) has recently gained popularity in patients with renal tumors because the disease-free survival rates are similar between radical nephrectomy and NSS. Pseudoaneurysms, arteriovenous fistulas, and hemorrhage due to vascular lacerations have been reported in these patients. The interventional radiologist plays a key role in the management of such lesions because most can be successfully treated endovascularly.

Appropriate arterial access is needed to manage severe congenital heart malformations. This access should be achieved by following strict protocols, with a limited number of punctures performed by experienced staff and only in large arteries. Residents-in-training should start developing their skills in large patients in a relatively stable condition and must be supervised at all times. Arterial tears are a rare but potentially lethal complication of CVC placement. Hypotension during or immediately after a jugular or subclavian puncture should be a warning of a serious event, usually a massive hemithorax. When a vascular lesion occurs in this setting, an endovascular approach is initially preferred because it has been demonstrated to be successful in most instances. If this fails, a surgical approach is required in the shortest time possible.

The benefit of ultrasonography-guided vascular access is reported in few randomized trials, limited so far to 4 studies.[6] Three of these studies support a higher success rate with cannulation of the internal jugular and common femoral veins (relative risk, 0.15; 95% confidence interval, 0.03–0.64).

Previous
Next

Pathophysiology

The usual sequence is arterial puncture, followed by spasm and thrombotic occlusion. The vascular endothelium has a predominant role in blood coagulation and has numerous interactions with perivascular cells and adjacent tissues. Several conditions predispose neonates to thrombotic complications, including congenital heart disease, polycythemia, sepsis, maternal diabetes or toxemia, dehydration, and low-flow states. Neonates also have lowered concentrations of antithrombin III, proteins C and S, and heparin cofactor II, resulting in a prothrombotic state. Evidence also suggests that fibrin sleeves form on catheters. Stripping of the sleeve with removal of the catheter may result in subsequent occlusion at the puncture site or distal embolization.

In a 32-month study, investigators monitored 76 children with regard to iatrogenic injury and found that all injuries involved the arteries of the lower extremities.[7] This finding is consistent with the trend away from puncture of the brachial artery for invasive diagnostic and monitoring procedures. In particular, the arterial injury is often at the level of the common femoral artery secondary to multiple attempts at arterial access in the groin.

In pediatric patients, iatrogenic vascular lesions associated with use of the femoral approach can be divided in ischemic and nonischemic injuries. The former can be further subdivided as acute or chronic. Acute ischemia occurs in 41.2% of patients, whereas chronic ischemia is reported in 20.6%. Nonischemic injuries include pseudoaneurysms, arteriovenous fistulas, hemorrhage, and hematomas.

Umbilical-artery catheters may perforate or tear the vessel, producing bleeding or aortoiliac occlusion due to thrombosis with microembolization and thus occluding a visceral artery.

Previous
Next

Presentation

Pediatric iatrogenic vascular lesions can be acute or can manifest late.

Signs and symptoms of vascular injuries are usually immediately apparent. Patients with limb ischemia present with the classic signs of distal hypoperfusion or cold skin plus the "5 Ps:" pulselessness, pallor, paralysis, paresthesia, and pain. Pulses can be difficult to palpate in infants and small children. However, Doppler technology can be used to confirm flow and compare pressures to the contralateral uninvolved limb.

Signs may be transient or may progress quickly to gangrene. Vascular spasm in children is inversely proportional to the size and age of the patient. Simple spasm usually subsides spontaneously within 3 hours. However, lesions suggestive of vascular compromise should not be attributed to spasm. The presence of pulses distal to the lesion does not completely rule out a vascular injury because as many as 25% of patients may have distal pulses even in the presence of a vascular insult.

Right-hand gangrene and necrosis secondary to use Right-hand gangrene and necrosis secondary to use of a brachial-artery catheter in very-low-birth-weight baby girl.

Patients with certain vascular injuries have a late presentation. Patients with arteriovenous fistulas, mycotic aneurysms, pseudoaneurysms, renal vascular occlusion with renovascular hypertension, intermittent claudication, or growth retardation of the affected extremity present with subtle signs and symptoms. Particular attention must be paid to poor capillary refill, coolness, diminished pulses, bruits, thrills, blanching, bluish discoloration, lack of movement, and mottling.

Not all patients with thrombosis develop clinical symptoms. On occasion, the vessel is only partially blocked, and collateral blood flow is adequate. This occurs with thromboses that are associated with umbilical-artery catheters. In a series of 4000 patients, only 1% of patients developed clinical symptoms of thrombosis.[1] Patients with acute aortic thrombosis secondary to umbilical-artery catheters can present with hypertension or congestive heart failure.

Previous
Next

Indications

Only a few absolute indications for surgical intervention in children with iatrogenic vascular injuries are noted. Any child with a nonviable limb should be taken to the operating room for definitive repair. Cases involving vascular injury, a lack of flow on Doppler study, or signs of neurologic deficit should be surgically explored. Late repair may be undertaken before the adolescent growth spurt occurs in some children with limb-length discrepancies.

Three strategies have been described and are based on the type of injury. Type I refers to life-threatening or limb-threatening lesions (hard signs). Patients with type I injuries require immediate surgical exploration. Type II includes lesions that do not immediately jeopardize limb integrity and that are not life-threatening; however, a vascular injury is evident. If available, Doppler study or preoperative angiography is the best first step. Otherwise, angiography can be performed during surgery. Type III includes the injuries without hard signs. However, because of their location and mechanism of injury, a vascular lesion should be suspected. These are best approached with angiography or CT angiography.

Acute aortic thrombosis is another absolute indication for surgery. Nonoperative therapy is associated with a 100% mortality rate, and several reports describe success with surgery for aortic thrombosis.

As surgeons become increasingly competent in repairing small vessels, the relative indications for repairing pediatric vascular lesions will increase.

Previous
Next

Relevant Anatomy

With umbilical-artery catheters, the pathway is through one of the 2 umbilical arteries into the internal iliac artery, the common iliac artery, and then the aorta. With transfemoral catheterization, the injury is at the level of the common femoral artery.

Previous
Next

Contraindications

Most neonates and children in the intensive care setting are poor surgical candidates because of their medical illnesses. In this case, the risks of surgery must be weighed against the risk of limb loss and limb growth discrepancy. If surgery is contraindicated, medical therapy (ie, heparin or thrombolytic agents) can be started.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Jaime Shalkow, MD  Head of Surgical Oncology, Division of Surgery, National Institute of Pediatrics, Mexico; Head-Professor of Pediatric Surgical Oncology, Universidad Nacional Autonoma de Mexico

Jaime Shalkow, MD is a member of the following medical societies: American College of Surgeons, International Society of Pediatric Surgical Oncology, Mexican Association of Pediatric Surgery, Mexican Association of Pediatrics, Mexican Society of Oncology, and Pacific Association of Pediatric Surgery

Disclosure: Nothing to disclose.

Coauthor(s)

Juan Miguel Rodriguez Trejo, MD  Chairman, Department of Vascular Surgery, Centro Medico Nacional, Mexico City

Disclosure: Nothing to disclose.

Manuel E Marquina Ramirez, MD  Resident Physician, Department of Vascular Surgery, Centro Medico Nacional, Mexico City

Disclosure: Nothing to disclose.

Nicholas A Shorter, MD  Professor of Clinical Surgery and Clinical Pediatrics, State University of New York-Downstate University; Division Chief, Department of Surgery, Division of Pediatric Surgery, State University of New York-Downstate Medical Center

Disclosure: Nothing to disclose.

Nayomi K Edirisinghe, MD  Instructor, Department of Surgery, Harvard Medical School; Consulting Staff, Cambridge Breast Center, Department of Surgery, Cambridge Health Alliance

Nayomi K Edirisinghe, MD is a member of the following medical societies: American College of Surgeons

Disclosure: Nothing to disclose.

Brian F Gilchrist, MD  Surgeon-in-Chief of Pediatric Surgery, The Floating Hospital for Children at Tufts-New England Medical Center; Associate Professor, Department of Surgery, Tufts University School of Medicine

Brian F Gilchrist, MD is a member of the following medical societies: American College of Surgeons, American Pediatric Surgical Association, and Society for Surgery of the Alimentary Tract

Disclosure: Nothing to disclose.

Marc S Lessin, MD  Consulting Surgeon, Children's Surgical Associates, PC

Marc S Lessin, MD is a member of the following medical societies: American College of Surgeons and American Pediatric Surgical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Jonah Odim, MD, PhD, MBA  Senior Medical Officer, Transplantation Immunology Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Jonah Odim, MD, PhD, MBA is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physician Executives, American College of Surgeons, American Heart Association, American Society for Artificial Internal Organs, American Society of Transplant Surgeons, Association for Academic Surgery, Association for Surgical Education, Canadian Cardiovascular Society, International Society for Heart and Lung Transplantation, National Medical Association, New York Academy of Sciences, Royal College of Physicians and Surgeons of Canada, Society of Critical Care Medicine, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

John Myers, MD  Director, Pediatric and Congenital Cardiovascular Surgery, Departments of Surgery and Pediatrics, Professor, Penn State Children's Hospital, Milton S Hershey Medical Center

John Myers, MD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Cardiology, American College of Surgeons, American Heart Association, American Medical Association, Congenital Heart Surgeons Society, Pennsylvania Medical Society, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

Mary C Mancini, MD, PhD  Professor and Chief, Cardiothoracic Surgery, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport

Mary C Mancini, MD, PhD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Phi Beta Kappa, Society of Thoracic Surgeons, and Southern Surgical Association

Disclosure: Nothing to disclose.

References
  1. O'Neill JA Jr, Neblett WW 3rd, Born ML. Management of major thromboembolic complications of umbilical artery catheters. J Pediatr Surg. Dec 1981;16(6):972-8. [Medline].

  2. Gamba P, Tchaprassian Z, Verlato F, Verlato G, Orzali A, Zanon GF. Iatrogenic vascular lesions in extremely low birth weight and low birth weight neonates. J Vasc Surg. Oct 1997;26(4):643-6. [Medline].

  3. Hoshal VL Jr, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg. Apr 1971;102(4):353-8. [Medline].

  4. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. Aug 8 2001;286(6):700-7. [Medline].

  5. Lin PH, Dodson TF, Bush RL, et al. Surgical intervention for complications caused by femoral artery catheterization in pediatric patients. J Vasc Surg. Dec 2001;34(6):1071-8. [Medline].

  6. Skippen P, Kissoon N. Ultrasound guidance for central vascular access in the pediatric emergency department. Pediatr Emerg Care. Mar 2007;23(3):203-7. [Medline].

  7. [Guideline] Flanigan DP, Keifer TJ, Schuler JJ, Ryan TJ, Castronuovo JJ. Experience with latrogenic pediatric vascular injuries. Incidence, etiology, management, and results. Ann Surg. Oct 1983;198(4):430-42. [Medline].

  8. Freed MD, Keane JF, Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation. Sep 1974;50(3):565-9. [Medline].

  9. Aspalter M, Domenig CM, Haumer M, Kitzmüller E, Kretschmer G, Hölzenbein TJ. Management of iatrogenic common femoral artery injuries in pediatric patients using primary vein patch angioplasty. J Pediatr Surg. Nov 2007;42(11):1898-902. [Medline].

  10. Balaguru D, Dilawar M, Ruff P, Radtke WA. Early and late results of thrombolytic therapy using tissue-type plasminogen activator to restore arterial pulse after cardiac catheterization in infants and small children. Am J Cardiol. Apr 1 2003;91(7):908-10. [Medline].

  11. Eulmesekian PG, Perez A, Minces PG, Lobos P, Moldes J, Garcia Monaco R. Internal mammary artery injury after central venous catheterization. Pediatr Crit Care Med. Sep 2007;8(5):489-91. [Medline].

  12. Freed MD, Rosenthal A, Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: use of percutaneous technique and aspirin. Am Heart J. Mar 1974;87(3):283-6. [Medline].

  13. Gault DT. Vascular compromise in newborn infants. Arch Dis Child. Apr 1992;67(4 Spec No):463-7. [Medline].

  14. Giswold ME, Landry GJ, Taylor LM, Moneta GL. Iatrogenic arterial injury is an increasingly important cause of arterial trauma. Am J Surg. May 2004;187(5):590-2; discussion 592-3. [Medline].

  15. Guzman MF. Trauma vascular periferico. Available at www.abcmedicus.com. Accessed 2006.

  16. Hogan MJ. Neonatal vascular catheters and their complications. Radiol Clin North Am. Nov 1999;37(6):1109-25. [Medline].

  17. LaQuaglia MP, Upton J, May JW Jr. Microvascular reconstruction of major arteries in neonates and small children. J Pediatr Surg. Sep 1991;26(9):1136-40. [Medline].

  18. Lopez-Gutierrez JC, Encinas JL, Luis A, Ros Z, Diaz M. [Arterial trauma in the first year of life]. An Pediatr (Barc). Sep 2003;59(3):290-3. [Medline].

  19. Myers SI, Reed MK, Black CT, Burkhalter KJ, Lowry PA. Noniatrogenic pediatric vascular trauma. J Vasc Surg. Sep 1989;10(3):258-65. [Medline].

  20. Nehler MR, Taylor LM Jr, Porter JM. Iatrogenic vascular trauma. Semin Vasc Surg. Dec 1998;11(4):283-93. [Medline].

  21. Ontell SJ, Gauderer MW. Iatrogenic arteriovenous fistula after multiple arterial punctures. Pediatrics. Jul 1985;76(1):97-8. [Medline].

  22. Pezzati M, Chiti G, Dani C, Rubaltelli FF. Cardiac tamponade with peripherally inserted central catheters. J Pediatr. Jun 2002;140(6):785; author reply 785-6. [Medline].

  23. Rodriguez TJ, et al. Iatrogenia vascular en pacientes pediatricos. Rev Mex Angiol. 2000;28:96-102.

  24. Rodriguez Trejo JM. Iatrogenia vascular en pacientes pediatricos. In: Iatrogenic Vascular Lesions. Manual Moderno: 2004:259-73.

  25. Smith C, Green RM. Pediatric vascular injuries. Surgery. Jul 1981;90(1):20-31. [Medline].

  26. Taneja M, Tan KT. Renal vascular injuries following nephron-sparing surgery and their endovascular management. Singapore Med J. Jan 2008;49(1):63-6. [Medline].

  27. Taylor LM Jr, Troutman R, Feliciano P, Menashe V, Sunderland C, Porter JM. Late complications after femoral artery catheterization in children less than five years of age. J Vasc Surg. Feb 1990;11(2):297-304; discussion 304-6. [Medline].

  28. Vlad P, Hohn A, Lambert EC. Retrograde arterial catheterization of the left heart. Experience with 500 infants and children. Circulation. May 1964;29:787-93. [Medline].

  29. Wali MA. Upper limb vascular trauma in the Asir region of Saudi Arabia. Ann Thorac Cardiovasc Surg. Oct 2002;8(5):298-301. [Medline].

  30. Ware JA, Simons M. Angiogenesis and Cardiovascular Disease. New York, NY: Oxford University; 1999:3-30.

Previous
Next
 
Right-hand gangrene and necrosis secondary to use of a brachial-artery catheter in very-low-birth-weight baby girl.
Superior vena cava syndrome in a patient with an intravenous access device (Port-A-Cath) in the right subclavian vein. Note the facial and upper torso edema, and the prominent collateral veins.
Close-up photograph of the same patient with the port incision and prominent collateral veins characteristic of superior vena cava syndrome secondary to catheter-related thrombotic complication.
A 6-month-old boy with severe superior vena cava syndrome after congenital cardiac surgery. Note the severe facial, neck, and upper-chest swelling and distended superficial veins.
Chest radiograph from the same patient above. It demonstrates soft tissue swelling, lung infiltrates, and a severely widened mediastinum. A central venous catheter is seen in place. The patient developed a superior vena cava thrombosis secondary to the central line.
Caval venogram depicts considerable narrowing of the infradiaphragmatic vena cava secondary to a right hepatic trisegmentectomy. The patient developed a mild inferior vena cava (IVC) syndrome, was treated nonsurgically (with heparinization), and recovered adequately, developing a collateral circulation without sequelae.
An expanded polytetrafluoroethylene (e-PTFE) graft placed between the right brachyocephalic trunk and the right common carotid artery in a 8-year-old boy with locally advanced medullary thyroid carcinoma, in which the artery was resected en-block with the tumor. Neuroprotection was employed during anesthesia. The patient recovered uneventfully without neurologic problems. The graft was placed slightly long to accommodate for growth.
Screen showing the internal jugular vein (arrow) and common carotid artery. Duplex blood flow and longitudinal view of the internal jugular vein with needle inside (white arrow).
Proposed algorithm in the treatment of pediatric vascular injury. UH = Unfractionated heparin, rt-PA = recombinant-tissue plasminogen activator.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.